William Weldon is Chairman and Chief Executive Officer of Johnson & Johnson and is the sixth Chairman in Johnson & Johnson's over one-hundred year history.
Weldon joined J&J as a sales representative for the McNeil Pharameutical division in 1971 and eventually became the head of J&J's Ethicon Endo-Surgery business in 1992. He became the head of J&J's pharmaceutical operations in 1998 and then became J&J's CEO in 2002. As CEO, Weldon engineered some of the largest acquisitions in J&J's history including the purchase of ALZA and Pfizer's consumer-health product line.
William Weldon received a BA in Biology from Quinnipiac University.
It starts with our Credo and our Credo is something that is not just written on a piece of paper, it was written over 65 years ago when J&J became a publicly health company, it was written by Robert Wood Johnson. It's not just a piece of paper but it is something that we practice, and I think that'...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
